ADIPOQ and atherosclerosis: Adiponectin supplementation suppresses the progression of viral myocarditis in diabetic obese mice [25], inhibits atherosclerosis progression in vitro by NF-κB inhibition and phospho-Akt activation [26], and suppresses TNFα-induced IκBα phosphorylation [27].